Multiple media outlets have covered MIG Capital’s press release on its 2025 business performance.

Several German media outlets, including “Manager Magazin,” are reporting on the IPO plans of MIG’s portfolio company IQM.

Frederick Michna, investment manager at MIG Capital, gives an overview of new market and technology trends in Germany’s VC scene in a guest article

The specialist magazine “Axios” reports on the latest funding round of the MIG portfolio company Glasspoint.

Among others, the Handelsblatt reports on a major milestone achieved by AC Immune, in which MIG is invested through its portfolio company Affiris, in its mission to develop an effective drug for the as yet incurable Parkinson’s disease.

Several international trade media outlets are reporting on MIG’s investment in the French deep tech start-up NcodiN.